Benitec Biopharma
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Benitec Biopharma generated cash of -$19,403,000, which is less than the previous year. Cash used in financing activities reached the amount of $68,029,000 last year. Net change in cash is therefore $48,439,000.
Cash Flow
| 2015 | -9.69M | -387.33K | 39.88K |
|---|---|---|---|
| 2016 | -20.20M | -255.39K | 17.51M |
| 2017 | -8.30M | -232.07K | 6.10M |
| 2018 | -8.55M | -107.98K | 6.24M |
| 2019 | 4.79M | -399.19K | -688.11K |
| 2020 | -7.53M | -94K | 1.77M |
| 2021 | -12.83M | -221K | 22.52M |
| 2022 | -15.89M | -13K | 0 |
| 2023 | -18.01M | -1K | 16.01M |
| 2024 | -19.40M | -179K | 68.02M |
BNTC Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 2.49M | 4.07M | 19.78M | 9.80M | 15.71M | 11.26M | 12.76M | 14.00M | 16.27M | 24.05M |
Operating activities | ||||||||||
Net income | -21.75M | -19.56M | -18.20M | -13.88M | -8.27M | 2.60M | -8.55M | -4.37M | -18.50M | -8.82M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 343K | 381K | 392K | 424K | 374K | 158K | 0 | 217K | 0 | 0 |
Stock-based compensation expense | 830K | 452K | 870K | 634K | 237K | 957.19K | 0 | 386K | 0 | 0 |
| Deferred income tax benefit | 830K | 452K | 870K | 634K | 237K | 957.19K | 0 | 386K | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | -50K | 1K | 28K | 2.39M | 607K | 0 | 0 | 0 | 0 |
Inventories | 0 | -1.30M | -1.09M | -83K | -700K | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 941K | 1.35M | 1.09M | 55K | -1.69M | 740K | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -19.40M | -18.01M | -15.89M | -12.83M | -7.53M | 4.79M | -8.55M | -8.30M | -20.20M | -9.69M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -131K | 0 | 0 |
Investments In Property Plant And Equipment | -179K | -1K | -13K | -221K | -95K | -403.39K | -60.97K | -131.40K | -255.39K | -387.33K |
Acquisitions Net | 0 | 0 | 0 | 0 | 1K | 4K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -179K | -1K | -13K | -221K | -94K | -399.19K | -107.98K | -232.07K | -255.39K | -387.33K |
Financing activities | ||||||||||
Common Stock Issued | 73.92M | 17.88M | 0 | 25.75M | 2.25M | 0 | 6.47M | 6.20M | 0 | 295.29K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 68.02M | 16.01M | 0 | 22.52M | 1.77M | -688.11K | 6.24M | 6.10M | 17.51M | 39.88K |
Net Change In Cash | 48.43M | -1.58M | -15.70M | 9.96M | -5.91M | 4.43M | -947.62K | -657.02K | -2.65M | -7.34M |
Cash at end of period | 50.92M | 2.49M | 4.07M | 19.76M | 9.80M | 15.69M | 11.81M | 13.35M | 13.61M | 16.71M |
| Data source | Data source | Data source | Data source | Data source |